In an ever-changing corporate landscape, complying with legal and ethical principles is a mark of our organizational success and good reputation. To follow is a summary of the actions we took in 2023, that show our commitment to transparency, accountability, and the highest standards of business integrity.

In 2023, we continued our commitment to compliance across global operations, addressing an array of different challenges and opportunities. As well as the recurring compliance risk assessment, delivering training, and monitoring the distribution network activity, the compliance function was mainly focused on the integration of the Transfusion and Transplant business lines, demonstrating our dedication to integrated and harmonized compliance practices across regions.

Additionally, we are committed to maintaining a transparent and accountable work environment, where employees feel empowered to report concerns about actual, or suspected, misconduct that could impact the company or employee’s well-being. To achieve this goal, we completed the implementation of the new version of the Ethics Channel, which is publicly available on our corporate website in 16 languages and ensures full confidentiality.

Finally, ongoing conflicts in some regions of the world have added additional complexity to the compliance regulatory framework. As a result, we have had to quickly adjust our protocols and controls to navigate these changing geopolitical dynamics.